The Clinical Development Program of Lixisenatide: A Once-Daily Glucagon-Like Peptide-1 Receptor Agonist

Overview of attention for article published in Diabetes Therapy, July 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#50 of 1,013)
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news: 2 news outlets

twitter: 1 X user

Readers on

mendeley: 32 Mendeley

So far, Altmetric has seen 1 X post from an account with 1,221 followers.

Online now in #Diabetes Therapy: The Clinical Development Program of Lixisenatide http://t.co/FrJOi4u7kp #openaccess

Reply Repost Favourite